Last reviewed · How we verify
0.8% Hyaluronic acid gel
At a glance
| Generic name | 0.8% Hyaluronic acid gel |
|---|---|
| Also known as | Gengigel |
| Sponsor | Marmara University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Effectiveness of Different Procedures on Palatinal Wound Healing After Free Gingival Graft Surgery. (NA)
- Effects of the Adjunctive Use of Hyaluronic Acid-based Gel With Coranally Advanced Flap in the Gingival Recession (PHASE1, PHASE2)
- Hyaluronic Acid With Connective Tissue Grafting for Gingival Recession (NA)
- Adjunctive 0.8% Hyaluronic Acid Gel in Open-Flap Surgery for Thin Gingival Phenotype in Patients With Periodontitis (NA)
- Does the Use of HA Gel Following Third Molar Extraction Decrease the Incidence of Alveolar Osteitis? (NA)
- Clinical Evaluation of Photobiomodulated Hyaluronic Acid Therapy for Interdental Papillary Loss: Minimal Invasive Blind Split Mouth Technique (PHASE1, PHASE2)
- Comparison of I-PRF, T-PRF, and 0.8% Hyaluronic Acid Applications in Wound Healing After Gingivectomy. (NA)
- Effects of the Adjunctive Use of Hyaluronic Acid-based Gel in the Surgical Periodontal Treatment of Periodontitis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 0.8% Hyaluronic acid gel CI brief — competitive landscape report
- 0.8% Hyaluronic acid gel updates RSS · CI watch RSS
- Marmara University portfolio CI